Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-05-30

Clinical Trial Update: Trop2-targeting NIR-II Molecular Probe for Guided Identification of Non-Muscle-Invasive Bladder Cancer

View source ↗

Summary

An update on a Trop2-targeting NIR-II molecular probe intended to help guide identification of non-muscle-invasive bladder cancer; the trial is currently recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Trop2-targeting NIR-II Molecular Probe

Snippet

Sponsor: Yunnan Cancer Hospital | Conditions: Non-Muscle-Invasive Bladder Cancer | Status: RECRUITING